Couto N, Wood J, Barber J
Likelihood of Accepting Treatment of GLP-1 vs Existing MOUD Options Does offering semaglutide or tirzepatide as one of the options for AUD or OUD treatment increase the likelihood of patients accepting treatment vs only offering existing therapies like naltrexone, buprenorphine, or methadone
Wegovy tablets may appeal to people who want to avoid injections, but Mounjaro currently has stronger clinical trial results and is already available in the UK
For many, a pre-workout supplement can provide that extra push needed to tackle challenging workouts, break through plateaus, and maintain consistency in their exercise routine, all contributing to effective weight management and improved fitness
This can be particularly beneficial when combined with tirzepatide's appetite-suppressing effects, as it may help patients feel satisfied with smaller portions whilst still meeting their nutritional needs